SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-24-053505
Filing Date
2024-06-18
Accepted
2024-06-18 06:10:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea0207116-defa14a_hoth.htm DEFA14A 14431
2 GRAPHIC image_001.jpg GRAPHIC 1763516
3 GRAPHIC image_002.jpg GRAPHIC 1238751
  Complete submission text file 0001213900-24-053505.txt   4149772
Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38803 | Film No.: 241050120
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)